1.88
-0.03(-1.57%)
Currency In USD
| Previous Close | 1.91 |
| Open | 1.9 |
| Day High | 1.93 |
| Day Low | 1.84 |
| 52-Week High | 10.5 |
| 52-Week Low | 1.72 |
| Volume | 28,072 |
| Average Volume | 132,330 |
| Market Cap | 18.15M |
| PE | -0.51 |
| EPS | -3.67 |
| Moving Average 50 Days | 2.14 |
| Moving Average 200 Days | 4.91 |
| Change | -0.03 |
If you invested $1000 in HOOKIPA Pharma Inc. (HOOK) since IPO date, it would be worth $13.43 as of February 05, 2025 at a share price of $1.88. Whereas If you bought $1000 worth of HOOKIPA Pharma Inc. (HOOK) shares 5 years ago, it would be worth $13.73 as of February 05, 2025 at a share price of $1.88.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
GlobeNewswire Inc.
Jan 30, 2025 12:00 PM GMT
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HIV) Under the collaboration agreement, HOOKIPA is r
HOOKIPA Pharma Inc - FORM 8 (OPD)
GlobeNewswire Inc.
Jan 08, 2025 4:23 PM GMT
NEW YORK and VIENNA, Austria, Jan. 08, 2025 (GLOBE NEWSWIRE) -- FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFERRules 8.1 and 8.2 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:HOOKIP
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements
GlobeNewswire Inc.
Jan 07, 2025 9:05 PM GMT
NEW YORK and VIENNA, Austria, Jan. 07, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a clinical-stage biopharmaceutical company developing next generation immunotherapeutics for the treatment of cancer and s